LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Blockade of interferon signaling decreases gut barrier integrity and promotes severe West Nile virus disease

    Shih-Ching Lin / Fang R. Zhao / Hana Janova / Adrian Gervais / Summer Rucknagel / Kristy O. Murray / Jean-Laurent Casanova / Michael S. Diamond

    Nature Communications, Vol 14, Iss 1, Pp 1-

    2023  Volume 16

    Abstract: Abstract The determinants of severe disease caused by West Nile virus (WNV) and why only ~1% of individuals progress to encephalitis remain poorly understood. Here, we use human and mouse enteroids, and a mouse model of pathogenesis, to explore the ... ...

    Abstract Abstract The determinants of severe disease caused by West Nile virus (WNV) and why only ~1% of individuals progress to encephalitis remain poorly understood. Here, we use human and mouse enteroids, and a mouse model of pathogenesis, to explore the capacity of WNV to directly infect gastrointestinal (GI) tract cells and contribute to disease severity. At baseline, WNV poorly infects human and mouse enteroid cultures and enterocytes in mice. However, when STAT1 or type I interferon (IFN) responses are absent, GI tract cells become infected, and this is associated with augmented GI tract and blood-brain barrier (BBB) permeability, accumulation of gut-derived molecules in the brain, and more severe WNV disease. The increased gut permeability requires TNF-α signaling, and is absent in WNV-infected IFN-deficient germ-free mice. To link these findings to human disease, we measured auto-antibodies against type I IFNs in serum from WNV-infected human cohorts. A greater frequency of auto- and neutralizing antibodies against IFN-α2 or IFN-ω is present in patients with severe WNV infection, whereas virtually no asymptomatic WNV-infected subjects have such antibodies (odds ratio 24 [95% confidence interval: 3.0 − 192.5; P = 0.003]). Overall, our experiments establish that blockade of type I IFN signaling extends WNV tropism to enterocytes, which correlates with increased gut and BBB permeability, and more severe disease.
    Keywords Science ; Q
    Subject code 616
    Language English
    Publishing date 2023-09-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Correction

    Daniela Matuozzo / Estelle Talouarn / Astrid Marchal / Peng Zhang / Jeremy Manry / Yoann Seeleuthner / Yu Zhang / Alexandre Bolze / Matthieu Chaldebas / Baptiste Milisavljevic / Adrian Gervais / Paul Bastard / Takaki Asano / Lucy Bizien / Federica Barzaghi / Hassan Abolhassani / Ahmad Abou Tayoun / Alessandro Aiuti / Ilad Alavi Darazam /
    Luis M. Allende / Rebeca Alonso-Arias / Andrés Augusto Arias / Gokhan Aytekin / Peter Bergman / Simone Bondesan / Yenan T. Bryceson / Ingrid G. Bustos / Oscar Cabrera-Marante / Sheila Carcel / Paola Carrera / Giorgio Casari / Khalil Chaïbi / Roger Colobran / Antonio Condino-Neto / Laura E. Covill / Ottavia M. Delmonte / Loubna El Zein / Carlos Flores / Peter K. Gregersen / Marta Gut / Filomeen Haerynck / Rabih Halwani / Selda Hancerli / Lennart Hammarström / Nevin Hatipoğlu / Adem Karbuz / Sevgi Keles / Christèle Kyheng / Rafael Leon-Lopez / Jose Luis Franco / Davood Mansouri / Javier Martinez-Picado / Ozge Metin Akcan / Isabelle Migeotte / Pierre-Emmanuel Morange / Guillaume Morelle / Andrea Martin-Nalda / Giuseppe Novelli / Antonio Novelli / Tayfun Ozcelik / Figen Palabiyik / Qiang Pan-Hammarström / Rebeca Pérez de Diego / Laura Planas-Serra / Daniel E. Pleguezuelo / Carolina Prando / Aurora Pujol / Luis Felipe Reyes / Jacques G. Rivière / Carlos Rodriguez-Gallego / Julian Rojas / Patrizia Rovere-Querini / Agatha Schlüter / Mohammad Shahrooei / Ali Sobh / Pere Soler-Palacin / Yacine Tandjaoui-Lambiotte / Imran Tipu / Cristina Tresoldi / Jesus Troya / Diederik van de Beek / Mayana Zatz / Pawel Zawadzki / Saleh Zaid Al-Muhsen / Mohammed Faraj Alosaimi / Fahad M. Alsohime / Hagit Baris-Feldman / Manish J. Butte / Stefan N. Constantinescu / Megan A. Cooper / Clifton L. Dalgard / Jacques Fellay / James R. Heath / Yu-Lung Lau / Richard P. Lifton / Tom Maniatis / Trine H. Mogensen / Horst von Bernuth / Alban Lermine / Michel Vidaud / Anne Boland / Jean-François Deleuze / Robert Nussbaum / Amanda Kahn-Kirby / France Mentre / Sarah Tubiana / Guy Gorochov / Florence Tubach / Pierre Hausfater / COVID Human Genetic Effort / COVIDeF Study Group / French COVID Cohort Study Group / CoV-Contact Cohort / COVID Clinicians / Orchestra Working Group / Amsterdam UMC Covid-19 Biobank / NIAID-USUHS COVID Study Group / Isabelle Meyts / Shen-Ying Zhang / Anne Puel / Luigi D. Notarangelo / Stephanie Boisson-Dupuis / Helen C. Su / Bertrand Boisson / Emmanuelle Jouanguy / Jean-Laurent Casanova / Qian Zhang / Laurent Abel / Aurélie Cobat

    Genome Medicine, Vol 16, Iss 1, Pp 1-

    Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    2024  Volume 3

    Keywords Medicine ; R ; Genetics ; QH426-470
    Language English
    Publishing date 2024-01-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Daniela Matuozzo / Estelle Talouarn / Astrid Marchal / Peng Zhang / Jeremy Manry / Yoann Seeleuthner / Yu Zhang / Alexandre Bolze / Matthieu Chaldebas / Baptiste Milisavljevic / Adrian Gervais / Paul Bastard / Takaki Asano / Lucy Bizien / Federica Barzaghi / Hassan Abolhassani / Ahmad Abou Tayoun / Alessandro Aiuti / Ilad Alavi Darazam /
    Luis M. Allende / Rebeca Alonso-Arias / Andrés Augusto Arias / Gokhan Aytekin / Peter Bergman / Simone Bondesan / Yenan T. Bryceson / Ingrid G. Bustos / Oscar Cabrera-Marante / Sheila Carcel / Paola Carrera / Giorgio Casari / Khalil Chaïbi / Roger Colobran / Antonio Condino-Neto / Laura E. Covill / Ottavia M. Delmonte / Loubna El Zein / Carlos Flores / Peter K. Gregersen / Marta Gut / Filomeen Haerynck / Rabih Halwani / Selda Hancerli / Lennart Hammarström / Nevin Hatipoğlu / Adem Karbuz / Sevgi Keles / Christèle Kyheng / Rafael Leon-Lopez / Jose Luis Franco / Davood Mansouri / Javier Martinez-Picado / Ozge Metin Akcan / Isabelle Migeotte / Pierre-Emmanuel Morange / Guillaume Morelle / Andrea Martin-Nalda / Giuseppe Novelli / Antonio Novelli / Tayfun Ozcelik / Figen Palabiyik / Qiang Pan-Hammarström / Rebeca Pérez de Diego / Laura Planas-Serra / Daniel E. Pleguezuelo / Carolina Prando / Aurora Pujol / Luis Felipe Reyes / Jacques G. Rivière / Carlos Rodriguez-Gallego / Julian Rojas / Patrizia Rovere-Querini / Agatha Schlüter / Mohammad Shahrooei / Ali Sobh / Pere Soler-Palacin / Yacine Tandjaoui-Lambiotte / Imran Tipu / Cristina Tresoldi / Jesus Troya / Diederik van de Beek / Mayana Zatz / Pawel Zawadzki / Saleh Zaid Al-Muhsen / Mohammed Faraj Alosaimi / Fahad M. Alsohime / Hagit Baris-Feldman / Manish J. Butte / Stefan N. Constantinescu / Megan A. Cooper / Clifton L. Dalgard / Jacques Fellay / James R. Heath / Yu-Lung Lau / Richard P. Lifton / Tom Maniatis / Trine H. Mogensen / Horst von Bernuth / Alban Lermine / Michel Vidaud / Anne Boland / Jean-François Deleuze / Robert Nussbaum / Amanda Kahn-Kirby / France Mentre / Sarah Tubiana / Guy Gorochov / Florence Tubach / Pierre Hausfater / COVID Human Genetic Effort / COVIDeF Study Group / French COVID Cohort Study Group / CoV-Contact Cohort / COVID-STORM Clinicians / COVID Clinicians / Orchestra Working Group / Amsterdam UMC Covid-19 Biobank / NIAID-USUHS COVID Study Group / Isabelle Meyts / Shen-Ying Zhang / Anne Puel / Luigi D. Notarangelo / Stephanie Boisson-Dupuis / Helen C. Su / Bertrand Boisson / Emmanuelle Jouanguy / Jean-Laurent Casanova / Qian Zhang / Laurent Abel / Aurélie Cobat

    Genome Medicine, Vol 15, Iss 1, Pp 1-

    2023  Volume 25

    Abstract: Abstract Background We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15–20% of cases of life-threatening COVID- ...

    Abstract Abstract Background We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15–20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in ~ 80% of cases. Methods We report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded. Results No gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5–528.7, P = 1.1 × 10−4) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR = 3.70[95%CI 1.3–8.2], P = 2.1 × 10−4). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR = 19.65[95%CI 2.1–2635.4], P = 3.4 × 10−3), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR = 4.40[9%CI 2.3–8.4], P = 7.7 × 10−8). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD] = 43.3 [20.3] years) than the other patients (56.0 [17.3] years; P = 1.68 × 10−5). Conclusions Rare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old.
    Keywords Rare variants ; COVID-19 ; Immunity ; Type I interferon ; Medicine ; R ; Genetics ; QH426-470
    Subject code 616
    Language English
    Publishing date 2023-04-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top